HomeCompanyTechnologyProduct CandidatesCareersNewsContact

Home
Welcome
welcome to Kenta Biotech and the leading product KBPA101
  » english  » german » imprint    

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

 Pioneering antibody therapies for life-threatening infections

We are a biotech company focused on the discovery and development of novel, fully human monoclonal antibodies for the prevention and treatment of serious bacterial and viral infections in the hospital setting.

Kenta's MabIgX® technology for the generation and selection of an advanced class of fully human monoclonal antibodies (MAbs) combines the advantages of classical hybridoma technology with a unique specific heteromyeloma fusion cell line.




Kenta Biotech Ltd.
Rehhagstrasse 79
CH - 3018 Berne		 Tel: +41 (0) 58 680 52 52
Fax: +41 (0) 58 680 52 51
info@kentabiotech.com